Members |
targetComponentId |
Fetal or neonatal effect of persistent occipito-posterior malposition during labor and delivery |
Fetal disorder due to persistent occipito-posterior malposition during labour |
Fetal or neonatal effect of persistent occipitoposterior position |
Fetal disorder due to persistent occipito-posterior malposition during labour |
Fetal or neonatal effect of placenta previa |
Perinatal disorder due to placenta praevia |
Fetal or neonatal effect of placenta previa |
Perinatal disorder due to placenta praevia |
Fetal or neonatal effect of placental damage caused by cesarean section |
Perinatal disorder due to placental damage due to caesarean section |
Fetal or neonatal effect of placental or breast transfer of alcohol |
Fetal disorder caused by maternal alcohol dependence in pregnancy |
Fetal or neonatal effect of polyhydramnios |
Fetal disorder due to polyhydramnios (disorder) |
Fetal or neonatal effect of prolapsed cord |
Perinatal disorder due to prolapsed cord |
Fetal or neonatal effect of shoulder presentation |
Fetal disorder due to shoulder presentation during labor |
Fetal or neonatal effect of shoulder presentation during labor and delivery |
Fetal disorder due to shoulder presentation during labor |
Fetal or neonatal effect of transverse lie |
Fetal disorder due to transverse lie |
Fetal or neonatal effect of transverse lie before labor |
Fetal disorder due to transverse lie before labor |
Fetal or neonatal effect of transverse lie before labor |
Fetal disorder due to transverse lie before labor |
Fetal or neonatal effect of transverse lie during labor and delivery |
Fetal disorder due to transverse lie during labor |
Fetal or neonatal effect of unstable lie before labor |
Fetal disorder due to unstable lie before labor |
Fetal or neonatal effect of unstable lie before labor |
Fetal disorder due to unstable lie before labor |
Fetal or neonatal effect of vacuum extraction delivery |
Disorder of early neonate and/or fetus during second intrapartum stage due to vacuum extraction delivery |
Fetal or neonatal intraventricular non-traumatic hemorrhage grade 4 |
Non-traumatic intraventricular hemorrhage grade 4 during intrapartum and/or early neonatal period (disorder) |
Fetal or neonatal period |
Fetal and/or neonatal period |
Fetal reduction or destruction procedure |
Destruction of fetus |
Fetishistic transvestism |
Fetishistic transvestism |
Fetus &/or neonate affected by malpresentation (& [before labor]) |
Fetal disorder due to malpresentation during prelabour |
Fetus &/or neonate affected by maternal polyhydramnios |
Fetal disorder due to polyhydramnios (disorder) |
Fetus OR newborn affected by external version before labor |
Fetal disorder due to external version before labor (disorder) |
Fetus OR newborn affected by premature rupture of membranes |
Fetal disorder due to premature rupture of membranes (disorder) |
Fetus OR newborn affected by prolapsed cord |
Perinatal disorder due to prolapsed cord |
Fetus or neonate affected by abnormal uterine contractions (& [hypertonic labor] or [uterine inertia]) |
Fetal disorder due to hypertonic uterine dysfunction (disorder) |
Fetus or neonate affected by chorioamnionitis |
Fetal disorder due to chorioamnionitis |
Fetus or neonate affected by destructive operation to aid delivery (& [destruction of fetus]) |
Fetal disorder due to destructive operation to facilitate delivery (disorder) |
Fetus or neonate affected by malpresentation before labor NOS |
Fetal disorder due to malpresentation during prelabour |
Fetus or neonate affected by other specified malpresentation before labor |
Fetal disorder due to malpresentation during prelabour |
Fetus or neonate affected by unspecified malpresentation before labor |
Fetal disorder due to malpresentation during prelabour |
Fetus or newborn affected by other specified abnormality of amnion, NEC |
Perinatal disorder of fetus and/or neonate due to abnormality of amnion |
Fetus or newborn affected by other specified abnormality of chorion, NEC |
Fetal disorder due to abnormality of chorion (disorder) |
Fetus poison - placenta/breast |
Fetal disorder caused by substance transmitted via placenta |
Fetus poison - placenta/breast |
Fetal disorder caused by substance transmitted via placenta |
Fetus with chromosomal abnormality (& suspect: [CF] or [mongol]) |
Suspected cystic fibrosis in fetus (situation) |
Fetus with damage NOS |
Fetal disorder |
Fetus with damage NOS |
Fetal disorder |
Fetus with damage due to other maternal disease |
Fetal disorder due to disease in mother (disorder) |
Fetus with damage due to other maternal disease - delivered |
Fetal disorder due to disease in mother (disorder) |
Fetus with damage due to other maternal disease NOS |
Fetal disorder due to disease in mother (disorder) |
Fetus with damage due to other maternal disease unspecified |
Fetal disorder due to disease in mother (disorder) |
Fetus with damage due to other maternal disease with antenatal problem |
Fetal disorder due to disease in mother (disorder) |
Fetus with hereditary disease NOS |
Fetus with hereditary disease |
Fetus with hereditary disease unspecified |
Fetus with hereditary disease |
Fetus with maternal problem NOS |
Fetal disorder due to disease in mother (disorder) |
Fetus with maternal problem NOS |
Fetal disorder due to disease in mother (disorder) |
Fetus with radiation damage with antenatal problem |
Fetus with radiation damage |
Fexofenadine 30mg/5mL oral suspension |
Product containing precisely fexofenadine hydrochloride 6 milligram/1 milliliter conventional release oral suspension (clinical drug) |
Fexofenadine hydrochloride + pseudoephedrine hydrochloride 60mg/120mg tablet |
Fexofenadine and pseudoephedrine only product |
Fexofenadine hydrochloride 180mg m/r tablet |
Fexofenadine only product in oral dose form |
Fexofenadine hydrochloride 180mg prolonged-release oral tablet |
Fexofenadine only product in oral dose form |
Fexofenadine hydrochloride+pseudoephedrine hydrochloride 180mg/240mg m/r tablet |
Fexofenadine and pseudoephedrine only product |
Fexofenadine hydrochloride+pseudoephedrine hydrochloride 180mg/240mg prolonged-release oral tablet |
Fexofenadine and pseudoephedrine only product |
Fexofenadine hydrochloride+pseudoephedrine hydrochloride 60mg/120 mg m/r tablet |
Fexofenadine and pseudoephedrine only product |
Fexofenadine hydrochloride+pseudoephedrine hydrochloride 60mg/120 mg prolonged-release oral tablet |
Fexofenadine and pseudoephedrine only product |
Fiancé of subject |
Fiance |
Fiber |
Plant fiber |
Fiberoptic esophagoscopy NEC |
Endoscopy of esophagus |
Fibreoptic bronchoscopy: [diagnostic NOS] or [NEC] |
Fibreoptic bronchoscopy |
Fibreoptic oesophagoscopy: [diagnostic NOS] or [NEC] |
Endoscopy of esophagus |
Fibrin AND/OR fibrinogen agent |
Coagulation related substance (substance) |
Fibrinolytic system finding |
Disorder involving the fibrinolytic system |
Fibroadenoma, no International Classification of Diseases for Oncology subtype |
Benign fibroadenoma (morphologic abnormality) |
Fibrocystic disease |
Nonproliferative fibrocystic disease (morphologic abnormality) |
Fibrohistiocytic neoplasm - category |
Fibrohistiocytic neoplasm (morphologic abnormality) |
Fibroma, no International Classification of Diseases for Oncology subtype |
Benign fibroma |
Fibromyalgia |
Fibromyositis |
Fibrous papule of the nose |
Papule |
Fibula X-ray |
Plain X-ray of fibula (procedure) |
Fifth day fits |
Self-limited neonatal epilepsy (disorder) |
Fifth ventricle |
Structure of cave of septum pellucidum (body structure) |
Filaricides |
Anthelmintic |
File root canal |
Root canal preparation |
Filgrastim 30million units/mL injection solution 1mL vial |
Product containing precisely filgrastim 300 microgram/1 milliliter conventional release solution for injection (clinical drug) |
Filgrastim 48million units/mL injection solution 1.6mL vial |
Product containing precisely filgrastim 300 microgram/1 milliliter conventional release solution for injection (clinical drug) |
Film-coated capsule |
Capsule |
Final report |
Final report (record artifact) |
Finances case management |
Management of financial circumstance (procedure) |
Finding |
Clinical finding (finding) |
Finding by site |
Clinical finding (finding) |
Finding of Aspergillus species not Aspergillus fumigatus |
Aspergillus species not Aspergillus fumigatus (organism) |
Finding of Bacillus species not anthracis |
Bacillus species not Bacillus anthracis (organism) |
Finding of Clostridium, not Clostridium perfringens |
Clostridium species, not Clostridium perfringens (organism) |
Finding of Corynebacterium species, not Corynebacterium diphtheriae |
Corynebacterium species, not Corynebacterium diphtheriae (organism) |
Finding of Corynebacterium species, not group JK |
Corynebacterium species not Corynebacterium jeikeium (organism) |
Finding of Mobiluncus-like gram-negative rod organism |
Mobiluncus-like gram-negative bacillus (organism) |
Finding of Moraxella catarrhalis, beta lactamase positive |
Moraxella catarrhalis, beta lactamase positive (organism) |
Finding of Moraxella-like organism |
Moraxella-like organism (organism) |
Finding of Moraxella-resembling organism |
Moraxella-like organism (organism) |
Finding of Mycobacterium Group 4 not Mycobacterium fortuitum complex |
Rapid growing Mycobacterium species not Mycobacterium fortuitum complex (organism) |
Finding of Mycobacterium species not Mycobacterium tuberculosis |
Mycobacterium, non-TB |
Finding of Mycoplasma species |
Genus Mycoplasma |
Finding of Mycoplasma species and ureaplasma positive |
Genus Mycoplasma |
Finding of Mycoplasma species, not Mycoplasma pneumoniae |
Mycoplasma species, not Mycoplasma pneumoniae (organism) |
Finding of Neisseria gonorrhoeae, beta lactamase negative |
Neisseria gonorrhoeae, beta lactamase negative (organism) |
Finding of Neisseria species not Neisseria gonococci |
Neisseria species not Neisseria gonococci (organism) |
Finding of Pneumocystis carinii present |
Pneumocystis jirovecii present (finding) |
Finding of absence of iris |
Congenital aniridia (disorder) |
Finding of active range of ankle extension |
Finding of active range of ankle plantar flexion (finding) |